Lv1
40 积分 2025-01-23 加入
Cytological changes in radiation-induced lung injury
8个月前
已完结
LBA48 CCTG BR.31: A global, double-blind placebo-controlled, randomized phase III study of adjuvant durvalumab in completely resected non-small cell lung cancer (NSCLC)
8个月前
已关闭
LBA48 CCTG BR.31: A global, double-blind placebo-controlled, randomized phase III study of adjuvant durvalumab in completely resected non-small cell lung cancer (NSCLC)
8个月前
已关闭
Perioperative Nivolumab in Resectable Lung Cancer
8个月前
已完结
Pembrolizumab for Early Triple-Negative Breast Cancer
8个月前
已完结
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
8个月前
已完结
皖公网安备34019202002308
